AMA November 1, 2023
What’s the news: Physicians can continue to prescribe controlled substances based on telehealth patient visits after the Drug Enforcement Administration (DEA) extended this regulatory flexibility through Dec. 31, 2024.
“The AMA is grateful the DEA recognizes patients being treated with these medications, including medication to treat opioid-use disorder, often have challenges securing and traveling to in-person appointments, and that the agency is committed to avoiding lapses in their care,” said AMA President Jesse M. Ehrenfeld, MD, MPH.
At a DEA “listening session” earlier this fall, Dr. Ehrenfeld urged the DEA to adopt federal policy on prescribing controlled substances based on telehealth visits that will continue to support patients’ access to evidence-based care. In his remarks (PDF), Dr. Ehrenfeld...
Today's Sponsors
Today's Sponsor